03.06.2013 Views

The Contribution of cocoa additive to cigarette smoking addiction

The Contribution of cocoa additive to cigarette smoking addiction

The Contribution of cocoa additive to cigarette smoking addiction

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Page 98 <strong>of</strong> 207 RIVM report 650270002<br />

Tryp<strong>to</strong>phan<br />

Animal<br />

LD50 oral rat: 1.6 g/kg (3, 5).<br />

LD50 intraperi<strong>to</strong>neal rat: 1.63 g/kg body weight (21).<br />

LD50 intraperi<strong>to</strong>neal mouse: 4.8 g/kg body weight (21).<br />

Local <strong>to</strong>lerance<br />

Human<br />

No data available<br />

Animal<br />

No data available<br />

Repeated dose <strong>to</strong>xicity<br />

Subacute<br />

No data available<br />

Semichronic<br />

Human<br />

Tryp<strong>to</strong>phan-containing products have been associated with the eosinophilia-myalgia<br />

syndrome in humans, but contamination <strong>of</strong> tryp<strong>to</strong>phan during the manufacturing<br />

process may have been responsible. Evidence pointed <strong>to</strong> contamination coming from<br />

a single manufacturer and the syndrome was probably caused by a bacitracin-like<br />

peptide. Tryp<strong>to</strong>phan probably promoted this disorder. Tryp<strong>to</strong>phan dosage ranged<br />

from 150 mg/day <strong>to</strong> 8.4 g/day, with duration <strong>of</strong> tryp<strong>to</strong>phan use ranging from 2 weeks<br />

<strong>to</strong> 8 years induced the eosinophilia-myalgia syndrome in humans (25).<br />

Chronic<br />

Animal<br />

Chronic administration <strong>of</strong> tryp<strong>to</strong>phan doses below the LD50 reduced the food intake<br />

and the growth <strong>of</strong> rats, due <strong>to</strong> amino acid imbalance.<br />

Large groups <strong>of</strong> rats and mice were given greatly elevated amounts <strong>of</strong> tryp<strong>to</strong>phan (2.5<br />

% or 5% (w/w) in food, equivalent <strong>to</strong> 6.25 or 12.5 g/kg BW and 0.94 or 1.88 g/kg<br />

BW respectively for mice and rats) in their diets for most <strong>of</strong> their lives (104 – 105<br />

weeks). In this study neither cancer incidence was increased nor gross microscopic<br />

changes in the tissue were observed at au<strong>to</strong>psy (10).<br />

A potential side effect <strong>of</strong> chronic tryp<strong>to</strong>phan use includes the risk <strong>of</strong> diabetes<br />

mellitus. Since xanthurenic acid, which is increased on tryp<strong>to</strong>phan loading, has<br />

diabe<strong>to</strong>genic action in animnals, tryp<strong>to</strong>phan may promote glucose in<strong>to</strong>lerance. In<br />

addition there is some evidence that pho<strong>to</strong>oxidation <strong>of</strong> tryp<strong>to</strong>phan and some <strong>of</strong> its<br />

metabolites, such as kynurenine, may be involved in cataract formation (10, 25).<br />

Carcinogenicity<br />

Human<br />

While tryp<strong>to</strong>phan itself seems <strong>to</strong> be relatively safe, during heating several pyrolysis<br />

products are formed which are mutagens, carcinogens and comutagens. No details are<br />

available on tryp<strong>to</strong>phan data from this study (10).<br />

It has been suggested that long-term tryp<strong>to</strong>phan use may promote bladder cancer.<br />

Elevated urinary levels <strong>of</strong> tryp<strong>to</strong>phan metabolites has been reported in both bladder<br />

cancer patients relative <strong>to</strong> controls, and in patients who had recurrence <strong>of</strong> cancer

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!